Table of Content

1 Liposomal Amphoteracin B Market Overview
1.1 Product Overview and Scope of Liposomal Amphoteracin B
1.2 Liposomal Amphoteracin B Segment by Type
1.2.1 Global Liposomal Amphoteracin B Market Value Comparison by Type (2024-2034)
1.2.2 25mg
1.2.3 50mg
1.3 Liposomal Amphoteracin B Segment by Application
1.3.1 Global Liposomal Amphoteracin B Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Liposomal Amphoteracin B Market Size Estimates and Forecasts
1.4.1 Global Liposomal Amphoteracin B Revenue 2018-2029
1.4.2 Global Liposomal Amphoteracin B Sales 2018-2029
1.4.3 Global Liposomal Amphoteracin B Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Liposomal Amphoteracin B Market Competition by Manufacturers
2.1 Global Liposomal Amphoteracin B Sales Market Share by Manufacturers (2018-2024)
2.2 Global Liposomal Amphoteracin B Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Liposomal Amphoteracin B Average Price by Manufacturers (2018-2024)
2.4 Global Liposomal Amphoteracin B Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Liposomal Amphoteracin B, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liposomal Amphoteracin B, Product Type & Application
2.7 Liposomal Amphoteracin B Market Competitive Situation and Trends
2.7.1 Liposomal Amphoteracin B Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Liposomal Amphoteracin B Players Market Share by Revenue
2.7.3 Global Liposomal Amphoteracin B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Liposomal Amphoteracin B Retrospective Market Scenario by Region
3.1 Global Liposomal Amphoteracin B Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Liposomal Amphoteracin B Global Liposomal Amphoteracin B Sales by Region: 2018-2029
3.2.1 Global Liposomal Amphoteracin B Sales by Region: 2018-2024
3.2.2 Global Liposomal Amphoteracin B Sales by Region: 2024-2029
3.3 Global Liposomal Amphoteracin B Global Liposomal Amphoteracin B Revenue by Region: 2018-2029
3.3.1 Global Liposomal Amphoteracin B Revenue by Region: 2018-2024
3.3.2 Global Liposomal Amphoteracin B Revenue by Region: 2024-2029
3.4 North America Liposomal Amphoteracin B Market Facts & Figures by Country
3.4.1 North America Liposomal Amphoteracin B Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Liposomal Amphoteracin B Sales by Country (2018-2029)
3.4.3 North America Liposomal Amphoteracin B Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Liposomal Amphoteracin B Market Facts & Figures by Country
3.5.1 Europe Liposomal Amphoteracin B Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Liposomal Amphoteracin B Sales by Country (2018-2029)
3.5.3 Europe Liposomal Amphoteracin B Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liposomal Amphoteracin B Market Facts & Figures by Country
3.6.1 Asia Pacific Liposomal Amphoteracin B Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Liposomal Amphoteracin B Sales by Country (2018-2029)
3.6.3 Asia Pacific Liposomal Amphoteracin B Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Liposomal Amphoteracin B Market Facts & Figures by Country
3.7.1 Latin America Liposomal Amphoteracin B Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Liposomal Amphoteracin B Sales by Country (2018-2029)
3.7.3 Latin America Liposomal Amphoteracin B Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liposomal Amphoteracin B Market Facts & Figures by Country
3.8.1 Middle East and Africa Liposomal Amphoteracin B Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Liposomal Amphoteracin B Sales by Country (2018-2029)
3.8.3 Middle East and Africa Liposomal Amphoteracin B Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Liposomal Amphoteracin B Sales by Type (2018-2029)
4.1.1 Global Liposomal Amphoteracin B Sales by Type (2018-2024)
4.1.2 Global Liposomal Amphoteracin B Sales by Type (2024-2029)
4.1.3 Global Liposomal Amphoteracin B Sales Market Share by Type (2018-2029)
4.2 Global Liposomal Amphoteracin B Revenue by Type (2018-2029)
4.2.1 Global Liposomal Amphoteracin B Revenue by Type (2018-2024)
4.2.2 Global Liposomal Amphoteracin B Revenue by Type (2024-2029)
4.2.3 Global Liposomal Amphoteracin B Revenue Market Share by Type (2018-2029)
4.3 Global Liposomal Amphoteracin B Price by Type (2018-2029)
5 Segment by Application
5.1 Global Liposomal Amphoteracin B Sales by Application (2018-2029)
5.1.1 Global Liposomal Amphoteracin B Sales by Application (2018-2024)
5.1.2 Global Liposomal Amphoteracin B Sales by Application (2024-2029)
5.1.3 Global Liposomal Amphoteracin B Sales Market Share by Application (2018-2029)
5.2 Global Liposomal Amphoteracin B Revenue by Application (2018-2029)
5.2.1 Global Liposomal Amphoteracin B Revenue by Application (2018-2024)
5.2.2 Global Liposomal Amphoteracin B Revenue by Application (2024-2029)
5.2.3 Global Liposomal Amphoteracin B Revenue Market Share by Application (2018-2029)
5.3 Global Liposomal Amphoteracin B Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Corporation Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Liposomal Amphoteracin B Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Gilead Sciences Liposomal Amphoteracin B Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 Cipla
6.2.1 Cipla Corporation Information
6.2.2 Cipla Description and Business Overview
6.2.3 Cipla Liposomal Amphoteracin B Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Cipla Liposomal Amphoteracin B Product Portfolio
6.2.5 Cipla Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liposomal Amphoteracin B Industry Chain Analysis
7.2 Liposomal Amphoteracin B Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liposomal Amphoteracin B Production Mode & Process
7.4 Liposomal Amphoteracin B Sales and Marketing
7.4.1 Liposomal Amphoteracin B Sales Channels
7.4.2 Liposomal Amphoteracin B Distributors
7.5 Liposomal Amphoteracin B Customers
8 Liposomal Amphoteracin B Market Dynamics
8.1 Liposomal Amphoteracin B Industry Trends
8.2 Liposomal Amphoteracin B Market Drivers
8.3 Liposomal Amphoteracin B Market Challenges
8.4 Liposomal Amphoteracin B Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Liposomal Amphoteracin B Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Liposomal Amphoteracin B Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Liposomal Amphoteracin B Market Competitive Situation by Manufacturers in 2022
Table 4. Global Liposomal Amphoteracin B Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Liposomal Amphoteracin B Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Liposomal Amphoteracin B Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Liposomal Amphoteracin B Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Liposomal Amphoteracin B Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Liposomal Amphoteracin B, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Liposomal Amphoteracin B, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Liposomal Amphoteracin B, Product Type & Application
Table 12. Global Key Manufacturers of Liposomal Amphoteracin B, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Liposomal Amphoteracin B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Amphoteracin B as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Liposomal Amphoteracin B Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Liposomal Amphoteracin B Sales by Region (2018-2024) & (K Units)
Table 18. Global Liposomal Amphoteracin B Sales Market Share by Region (2018-2024)
Table 19. Global Liposomal Amphoteracin B Sales by Region (2024-2029) & (K Units)
Table 20. Global Liposomal Amphoteracin B Sales Market Share by Region (2024-2029)
Table 21. Global Liposomal Amphoteracin B Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Liposomal Amphoteracin B Revenue Market Share by Region (2018-2024)
Table 23. Global Liposomal Amphoteracin B Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Liposomal Amphoteracin B Revenue Market Share by Region (2024-2029)
Table 25. North America Liposomal Amphoteracin B Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Liposomal Amphoteracin B Sales by Country (2018-2024) & (K Units)
Table 27. North America Liposomal Amphoteracin B Sales by Country (2024-2029) & (K Units)
Table 28. North America Liposomal Amphoteracin B Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Liposomal Amphoteracin B Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Liposomal Amphoteracin B Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Liposomal Amphoteracin B Sales by Country (2018-2024) & (K Units)
Table 32. Europe Liposomal Amphoteracin B Sales by Country (2024-2029) & (K Units)
Table 33. Europe Liposomal Amphoteracin B Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Liposomal Amphoteracin B Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Liposomal Amphoteracin B Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Liposomal Amphoteracin B Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Liposomal Amphoteracin B Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Liposomal Amphoteracin B Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Liposomal Amphoteracin B Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Liposomal Amphoteracin B Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Liposomal Amphoteracin B Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Liposomal Amphoteracin B Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Liposomal Amphoteracin B Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Liposomal Amphoteracin B Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Liposomal Amphoteracin B Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Liposomal Amphoteracin B Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Liposomal Amphoteracin B Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Liposomal Amphoteracin B Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Liposomal Amphoteracin B Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Liposomal Amphoteracin B Sales (K Units) by Type (2018-2024)
Table 51. Global Liposomal Amphoteracin B Sales (K Units) by Type (2024-2029)
Table 52. Global Liposomal Amphoteracin B Sales Market Share by Type (2018-2024)
Table 53. Global Liposomal Amphoteracin B Sales Market Share by Type (2024-2029)
Table 54. Global Liposomal Amphoteracin B Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Liposomal Amphoteracin B Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Liposomal Amphoteracin B Revenue Market Share by Type (2018-2024)
Table 57. Global Liposomal Amphoteracin B Revenue Market Share by Type (2024-2029)
Table 58. Global Liposomal Amphoteracin B Price (US$/Unit) by Type (2018-2024)
Table 59. Global Liposomal Amphoteracin B Price (US$/Unit) by Type (2024-2029)
Table 60. Global Liposomal Amphoteracin B Sales (K Units) by Application (2018-2024)
Table 61. Global Liposomal Amphoteracin B Sales (K Units) by Application (2024-2029)
Table 62. Global Liposomal Amphoteracin B Sales Market Share by Application (2018-2024)
Table 63. Global Liposomal Amphoteracin B Sales Market Share by Application (2024-2029)
Table 64. Global Liposomal Amphoteracin B Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Liposomal Amphoteracin B Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Liposomal Amphoteracin B Revenue Market Share by Application (2018-2024)
Table 67. Global Liposomal Amphoteracin B Revenue Market Share by Application (2024-2029)
Table 68. Global Liposomal Amphoteracin B Price (US$/Unit) by Application (2018-2024)
Table 69. Global Liposomal Amphoteracin B Price (US$/Unit) by Application (2024-2029)
Table 70. Gilead Sciences Corporation Information
Table 71. Gilead Sciences Description and Business Overview
Table 72. Gilead Sciences Liposomal Amphoteracin B Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Gilead Sciences Liposomal Amphoteracin B Product
Table 74. Gilead Sciences Recent Developments/Updates
Table 75. Cipla Corporation Information
Table 76. Cipla Description and Business Overview
Table 77. Cipla Liposomal Amphoteracin B Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Cipla Liposomal Amphoteracin B Product
Table 79. Cipla Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Liposomal Amphoteracin B Distributors List
Table 83. Liposomal Amphoteracin B Customers List
Table 84. Liposomal Amphoteracin B Market Trends
Table 85. Liposomal Amphoteracin B Market Drivers
Table 86. Liposomal Amphoteracin B Market Challenges
Table 87. Liposomal Amphoteracin B Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Liposomal Amphoteracin B
Figure 2. Global Liposomal Amphoteracin B Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Liposomal Amphoteracin B Market Share by Type in 2022 & 2029
Figure 4. 25mg Product Picture
Figure 5. 50mg Product Picture
Figure 6. Global Liposomal Amphoteracin B Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Liposomal Amphoteracin B Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Liposomal Amphoteracin B Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Liposomal Amphoteracin B Market Size (2018-2029) & (US$ Million)
Figure 12. Global Liposomal Amphoteracin B Sales (2018-2029) & (K Units)
Figure 13. Global Liposomal Amphoteracin B Average Price (US$/Unit) & (2018-2029)
Figure 14. Liposomal Amphoteracin B Report Years Considered
Figure 15. Liposomal Amphoteracin B Sales Share by Manufacturers in 2022
Figure 16. Global Liposomal Amphoteracin B Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Liposomal Amphoteracin B Players: Market Share by Revenue in 2022
Figure 18. Liposomal Amphoteracin B Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Liposomal Amphoteracin B Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Liposomal Amphoteracin B Sales Market Share by Country (2018-2029)
Figure 21. North America Liposomal Amphoteracin B Revenue Market Share by Country (2018-2029)
Figure 22. United States Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Liposomal Amphoteracin B Sales Market Share by Country (2018-2029)
Figure 25. Europe Liposomal Amphoteracin B Revenue Market Share by Country (2018-2029)
Figure 26. Germany Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Liposomal Amphoteracin B Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Liposomal Amphoteracin B Revenue Market Share by Region (2018-2029)
Figure 33. China Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Liposomal Amphoteracin B Sales Market Share by Country (2018-2029)
Figure 43. Latin America Liposomal Amphoteracin B Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Liposomal Amphoteracin B Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Liposomal Amphoteracin B Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Liposomal Amphoteracin B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Liposomal Amphoteracin B by Type (2018-2029)
Figure 53. Global Revenue Market Share of Liposomal Amphoteracin B by Type (2018-2029)
Figure 54. Global Liposomal Amphoteracin B Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Liposomal Amphoteracin B by Application (2018-2029)
Figure 56. Global Revenue Market Share of Liposomal Amphoteracin B by Application (2018-2029)
Figure 57. Global Liposomal Amphoteracin B Price (US$/Unit) by Application (2018-2029)
Figure 58. Liposomal Amphoteracin B Value Chain
Figure 59. Liposomal Amphoteracin B Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed